LATEST PUBLICATIONS
PIDS EPM 2020-2021
Reset and Rebuild for a Better Philippines in the Post-pandemic World
DLSU-AKI Working Paper Series 2021-11-079
Examining and Evaluating the Multidimensional Energy Poverty Index (MEPI) in the Philippine Household Context
DLSU-AKI Working Paper Series 2021-11-078
A Game Theoretic Study on CSR and Government Intervention for Sustainable Production
DLSU-AKI Working Paper Series 2021-11-077
Obstacles to Economic Freedom Affecting Micro, Small, and Medium Enterprises (MSMEs) in Southeast Asian Countries

LATEST AV MATERIALS
PIDS WB 2021-1104
Assessing the Philippines' Performance in Meeting the ASEAN Economic Community Vision 2025
PIDS WB 2021-1103
Examining The Health Impacts Of The COVID-19 Pandemic In The Philippines
ILS-AVP-01
ILS 30th Anniversary Video
PIDS WB 2021-1102
Evaluating the Pantawid Pamilyang Pilipino Program's Payment System
Publication Detail
DP 2011-11: A Profile of the Philippine Pharmaceutical Sector

The Philippines is one of the biggest pharmaceutical markets in the ASEAN region, next only to Indonesia and Thailand. It is a lifeline to thousands of Filipino workers and a significant contributor in terms of value of output. This industry is one of the fastest growing industries in the country. Meanwhile, its output, drugs and medicines, account for 46 percent of the total medical out-of-pocket expenses of Philippine households. For poorer people, this percentage goes up to 55 percent. Making essential drugs and medicines more affordable especially to the poor and underserved is one of the Millennium Development Goals (MDGs). It is therefore essential to examine the profile of the pharmaceutical industry in the country to better understand the supply chain of drugs and medicines for policy formulation purposes. Using administrative data from agencies that have regulative powers over the industry, a profile of the Philippine pharmaceutical industry was developed. As of December 2009, the Food and Drug Administration’s records show that there are 284 drug manufacturers, 438 drug traders, 634 drug importers, 4,719 drug distributors of which 3,956 are wholesalers, and 32,538 retail outlets. Manufacturing is dominated by multinational brand originator giants and numerous local generics/branded generics producers. Meanwhile, trading is done by few large companies and thousands of small retail outlets. The industry players are diverse and formulating policies therefore must take into consideration how each player may be affected by policy issuances.

Philippine Institute for Development Studies
Authors Keywords
Tabuga, Aubrey D.; Lavado, Rouselle F.; Reyes, Celia M.; Asis, Ronina D.; Datu, Maria Blesila G.; drugs/medicine; Philippines; Geographic Information System (GIS); macroeconomic shock; Philippine pharmaceutical sector;
Download PDF Number of Downloads
Published in 2011 and available in the PIDS Library or Downloaded 4,358 times since November 05, 2013
×
Please let us know your reason for downloading this publication. May we also ask you to provide additional information that will help us serve you better? Rest assured that your answers will not be shared with any outside parties. It will take you only two minutes to complete the survey. Thank you.


To use as reference:
If others, (Please specify):
Name: (optional)
Email: (required, but will not display)
Age:
Gender:
If Prefer to self-describe, please specify:
Level of Education:
Occupation:
If employed either part-time or full-time, name of office:
If others, (Please specify):
Would you like to receive the SERP-P UPDATES e-newsletter? Yes No
Use the space below if you have any comment about this publication or SERP-P knowledge resources in general.